. 2020 Aug 6;68(2):833–845. doi: 10.1111/tbed.13749

Table 3a.

Summary of clinical scores, post‐mortem diagnostics and pig performance from Experiment 2

Treatment	Clinical scores			Post‐mortem diagnostics			Performance
Treatment	Diarrhoea	Lameness	Dyspnoea	Rectal swab	Serum	Tonsil	ADG (kg)	Mortality
SalCURB^®	0%^a	0%^a	0%^a	0/30^a	0/6^a	0/30^a	0.42^a	0%
CaptiSURE™ 1.0%	0%^a	0%^a	0%^a	0/30^a	0/6^a	0/30^a	0.43^a	0%
(+) control	100%^b	17%^a	100%^b	5/30^b	6/6^b	13/30^b	0.35^b	4%
p‐value	.0001	.35	.0001	.005	.0001	<.0001	<.0001	NA

Difference in superscripts (a/b) indicates a difference in significance of p < .05. Clinical scores are based on visual observations across the 6 pens in each room on days 6 and 15 post‐inoculation. Post‐mortem diagnostic data are based on results from 30 of 96 pigs from each room necropsied on day 15 post‐inoculation. Rectal swabs were tested for the presence of PEDV RNA, serum samples (pooled 5:1) were tested for the presence of PRRSV RNA, and tonsils were tested for the presence of SVA RNA. Performance data are summarized by room.